Shah, Syed AhmarRobertson, ChrisRudan, IgorMurray, Josephine LkMcCowan, ColinGrange, ZoeBuelo, AudreySullivan, ChristopherSimpson, Colin RRitchie, Lewis DSheikh, Aziz2022-04-072022-04-072022-03-26Shah, S A, Robertson, C, Rudan, I, Murray, J L, McCowan, C, Grange, Z, Buelo, A, Sullivan, C, Simpson, C R, Ritchie, L D & Sheikh, A 2022, 'BNT162b2 and ChAdOx1 nCoV-19 vaccinations, incidence of SARS-CoV-2 infections and COVID-19 hospitalisations in Scotland in the Delta era', Journal of Global Health, vol. 12, 05008. https://doi.org/10.7189/jogh.12.050082047-2978PubMedCentral: PMC8942298https://hdl.handle.net/2164/18361EAVE II is supported by the Medical Research Council (MR/R008345/1) with the support of BREATHE – The Health Data Research Hub for Respiratory Health, which is funded through the UK Research and Innovation Industrial Strategy Challenge Fund [MC_PC_19004] and delivered through Health Data Research UK. Additional support has been provided through Public Health Scotland and Scottish Government DG Health and Social Care, the Data and Connectivity National Core Study, led by Health Data Research UK in partnership with the Office for National Statistics and funded by UK Research and Innovation (grant ref MC_PC_20058) and the Lifelong Health and Well-being study as part of the National Core Studies (MC_PC_20030).113250926engSDG 3 - Good Health and Well-beingAdultAgedBNT162 VaccineCOVID-19/epidemiologyChAdOx1 nCoV-19HospitalizationHumansIncidenceSARS-CoV-2VaccinationViral VaccinesYoung AdultR MedicineMedical Research Council (MRC)MR/R008345/1Supplementary InformationRJournal article10.7189/jogh.12.05008https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942298/?report=classic12